Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 727 | 1,444 | 7,426 | 8,415 | 860 |
Marketable Securities | 1,860 | 8,332 | 12,700 | 17,394 | 0 |
Receivables | 1,149 | 1,273 | 193 | 447 | 80 |
Inventories | 185 | 461 | N/A | N/A | 0 |
Other current assets | 0 | 0 | 0 | 0 | 130 |
TOTAL | $4,819 | $12,362 | $20,930 | $26,389 | $1,070 |
Non-Current Assets | |||||
PPE Net | 1,004 | 742 | 477 | 116 | 100 |
Investments And Advances | 0 | 0 | 0 | 0 | 150 |
Intangibles | 4,887 | 5,308 | 2,642 | 3,002 | 0 |
Other Non-Current Assets | 1,101 | 1,075 | 1,438 | 1,019 | 3,268 |
TOTAL | $6,992 | $7,125 | $4,557 | $4,137 | $3,518 |
Total Assets | $11,811 | $19,487 | $25,487 | $30,526 | $4,600 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 338 | 789 | 107 | N/A | 0 |
Accounts payable and accrued liabilities | 1,780 | 2,469 | 1,486 | 1,158 | 720 |
Accrued Expenses | 311 | 311 | 310 | 283 | 70 |
Other current liabilities | N/A | N/A | N/A | N/A | 150 |
TOTAL | $3,613 | $4,768 | $2,411 | $1,992 | $980 |
Non-Current Liabilities | |||||
Long Term Debt | 282 | 354 | 468 | N/A | 0 |
Deferred Revenues | 1,184 | 1,199 | 508 | 551 | N/A |
aiOther Non-Current Liabilities | 13,741 | 13,876 | 13,530 | 13,530 | 0 |
TOTAL | $14,023 | $14,230 | $13,998 | $13,530 | $N/A |
Total Liabilities | $17,636 | $18,998 | $16,409 | $15,522 | $980 |
Shareholders' Equity | |||||
Shares Outstanding, K | 2 | 2 | 2 | N/A | N/A |
Common Shares | 134 | 132 | 132 | 132 | 60 |
Retained earnings | -54,227 | -47,292 | -37,908 | -31,881 | -26,450 |
Other shareholders' equity | -1,329 | -1,340 | -1,203 | -1,049 | 0 |
TOTAL | $-5,825 | $489 | $9,078 | $15,004 | $3,610 |
Total Liabilities And Equity | $11,811 | $19,487 | $25,487 | $30,526 | $4,590 |